Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Neuropsychopharmacology

• Publication date

  2016-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.euroneuro.2016.03.009PMID 27061850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine

  2016cited by this paper
• Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice.

  2015cited by this paper
• The modulation of NMDA receptors and l-arginine/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test

  2015cited by this paper
• Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc.

  2015cited by this paper
• Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice

  2015cited by this paper
• The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity?

  2015cited by this paper
• Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice.

  2014cited by this paper
• Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway.

  2014cited by this paper
• BDNF Release Is Required for the Behavioral Actions of Ketamine

  2014cited by this paper
• Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections

  2014cited by this paper
• ConBr, a lectin from Canavalia brasiliensis seeds, modulates signaling pathways and increases BDNF expression probably via a glycosylated target

  2014cited by this paper
• Depressive-like behavior induced by tumor necrosis factor-α is abolished by agmatine administration.

  2014cited by this paper
• GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine

  2013cited by this paper
• Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress.

  2013cited by this paper
• Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants.

  2013cited by this paper
• Agmatine: clinical applications after 100 years in translation.

  2013cited by this paper
• Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression

  2013cited by this paper
• The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.

  2013cited by this paper
• Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3β, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients.

  2013cited by this paper
• Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.

  2012cited by this paper
• Signaling pathways underlying the rapid antidepressant actions of ketamine.

  2012cited by this paper
• Depressive-like behavior induced by tumor necrosis factor-α in mice.

  2012cited by this paper
• In Vivo Manganese Exposure Modulates Erk, Akt and Darpp-32 in the Striatum of Developing Rats, and Impairs Their Motor Function

  2012cited by this paper
• mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade.

  2012cited by this paper
• Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways.

  2012cited by this paper
• Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.

  2011cited by this paper
• AKAP Signaling Complexes in Regulation of Excitatory Synaptic Plasticity

  2011cited by this paper
• Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice

  2011cited by this paper
• The Hippocampus, Neurotrophic Factors and Depression

  2011cited by this paper
• NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses

  2011cited by this paper
• Spatial learning-induced accumulation of agmatine and glutamate at hippocampal CA1 synaptic terminals.

  2011cited by this paper
• Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation.

  2011cited by this paper
• The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder.

  2011cited by this paper
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010influential reference
• Altered expression of glutamate signaling, growth factor and glia genes in the locus coeruleus of patients with major depression

  2010cited by this paper
• Synaptic AMPA receptor plasticity and behavior.

  2009cited by this paper
• Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression.

  2009cited by this paper
• Positive modulation of AMPA receptors prevents downregulation of GluR2 expression and activates the Lyn‐ERK1/2‐CREB signaling in rat brain ischemia

  2009cited by this paper
• Akt/GSK3 signaling in the action of psychotropic drugs.

  2009cited by this paper
• Ketamine and the next generation of antidepressants with a rapid onset of action.

  2009cited by this paper
• Future Antidepressant Targets: Neurotrophic Factors and Related Signaling Cascades.

  2008cited by this paper
• Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

  2008cited by this paper
• Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.

  2008cited by this paper
• Lower Phosphoinositide 3-Kinase (PI 3-kinase) Activity and Differential Expression Levels of Selective Catalytic and Regulatory PI 3-Kinase Subunit Isoforms in Prefrontal Cortex and Hippocampus of Suicide Subjects

  2008cited by this paper
• AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression

  2008cited by this paper
• Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus.

  2008cited by this paper
• Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

  2008cited by this paper
• PSD-95 is required for activity-driven synapse stabilization

  2007cited by this paper
• Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims.

  2007cited by this paper
• The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects

  2007cited by this paper
• Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38MAPK and JNK1/2 but not of ERK1/2

  2007cited by this paper
• Editorial [Hot Topic: Depression (Part 2) (Guest Editors: Ronald S. Duman and John H. Kehne)]

  2007cited by this paper
• New approaches to antidepressant drug discovery: beyond monoamines

  2006cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons.

  2006cited by this paper
• Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test.

  2005cited by this paper
• AMPA receptor potentiators as novel antidepressants.

  2005cited by this paper
• Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.

  2005cited by this paper
• Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test.

  2004cited by this paper
• AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.

  2004cited by this paper
• Postsynaptic Density 95 controls AMPA Receptor Incorporation during Long-Term Potentiation and Experience-Driven Synaptic Plasticity

  2004cited by this paper
• The tail suspension test: A new method for screening antidepressants in mice

  2004cited by this paper
• Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.

  2003cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity

  2003cited by this paper
• Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory.

  2003cited by this paper
• Effect of Agmatine Against Cell Death Induced by NMDA and Glutamate in Neurons and PC12 Cells

  2003cited by this paper
• BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents

  2002cited by this paper
• Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression

  2002cited by this paper
• Agmatine produces antidepressant-like effects in two models of depression in mice

  2002cited by this paper
• An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study.

  2002cited by this paper
• Research and treatment approaches to depression

  2001cited by this paper
• Positive Modulation of AMPA Receptors Increases Neurotrophin Expression by Hippocampal and Cortical Neurons

  2000cited by this paper
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466.

  2000cited by this paper
• Antidepressants for the new millennium.

  1999cited by this paper
• Protection by imidazol(ine) drugs and agmatine of glutamate‐induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor

  1999cited by this paper
• Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

  1997cited by this paper
• Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non‐NMDA glutamate receptors.

  1990cited by this paper
• A simplification of the protein assay method of Lowry et al. which is more generally applicable.

  1977cited by this paper

• Agmatine augmentation in treatment-resistant obsessive-compulsive disorder: a prospective open-label case series.

  2026cites this paper
• Agmatine diminishes pro-inflammatory response by modulating IL-1β and NF-κB expression in the prefrontal cortex and reverses behavioral impairments following chronic social isolation in rats.

  2026cites this paper
• Investigation of structural suitability of agmatine with glutamatergic ion channels: Molecular docking study

  2025cites this paper
• Agmatine Enhances Dorsal Raphe Serotonergic Neuronal Activity via Dual Regulation of 5-HT1B and 5-HT2A Receptors

  2025cites this paper
• Agmatine diminishes behavioral and endocrine alterations in a rat model of post-traumatic stress disorder.

  2024cites this paper
• Mitigating effects of agmatine on myocardial infarction in rats subjected to isoproterenol

  2024cites this paper
• Agmatine Modulation of Gut-Brain Axis Alleviates Dysbiosis-Induced Depression-like Behaviour in Rats.

  2024cites this paper
• New insights about the antidepressant-like effects of riparin A in a chronic murine model of depression

  2024cites this paper
• Agmatine as a Novel Intervention for Alzheimer's Disease: Pathological Insights and Cognitive Benefits.

  2024cites this paper
• PI3K-AKT/mTOR Signaling in Psychiatric Disorders: A Valuable Target to Stimulate or Suppress?

  2024cites this paper
• Perspectives on agmatine neurotransmission in acute and chronic stress-related conditions.

  2023cites this paper
• Neuroprotection by agmatine: Possible involvement of the gut microbiome?

  2023cites this paper
• Preventive putative effect of agmatine on cognitive and molecular outcomes in ventral tegmental area of male offspring following physical and psychological prenatal stress.

  2023cites this paper
• The effect of maternal separation stress-induced depression on ovarian reserve in Sprague Dawley Rats: The possible role of imipramine and agmatine through a mTOR signal pathway.

  2023cites this paper
• Administration of agmatine prior to physical or psychological stress in pregnant mice ameliorates behavioural and cognitive deficits in female offspring

  2023cites this paper
• The expression of agmatinase manipulates the affective state of rats subjected to chronic restraint stress.

  2023cites this paper
• Agmatine Reduces Alcohol Drinking and Produces Antinociceptive Effects in Rodent Models of Alcohol Use Disorder.

  2023cites this paper
• New Insights Into the Pivotal Role of CREB-Regulated Transcription Coactivator 1 in Depression and Comorbid Obesity

  2022cites this paper
• Fingolimod Alleviates Cognitive Deficit in Type 2 Diabetes by Promoting Microglial M2 Polarization via the pSTAT3-jmjd3 Axis

  2022cites this paper
• Anti-depressant-like effect of fermented Gastrodia elata Bl. by regulating monoamine levels and BDNF/NMDAR pathways in mice.

  2022cites this paper
• Guanosine boosts the fast, but not sustained, antidepressant-like and pro-synaptogenic effects of ketamine by stimulating mTORC1-driven signaling pathway.

  2022cites this paper
• Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling

  2021cites this paper
• The effects of subchronic agmatine on passive avoidance memory, anxiety-like behavior and hippocampal Akt/GSK-3β in mice

  2021cites this paper
• Agmatine as a novel candidate for rapid-onset antidepressant response

  2021cites this paper
• Generation of process-induced toxicants

  2021cites this paper
• Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response

  2021cites this paper
• Behavioral and neurochemical effects of folic acid in a mouse model of depression induced by TNF-α.

  2021cites this paper
• Agmatine has beneficial effect on harmaline-induced essential tremor in rat.

  2021cites this paper
• DNA methylation in stress and depression: from biomarker to therapeutics.

  2021cites this paper
• Involvement of Agmatine in Antidepressant-like Effect of HMG- CoA Reductase Inhibitors in Mice.

  2020cites this paper
• Inhibitory Influence of Agmatine in Ethanol Withdrawal-Induced Depression in Rats: Behavioral and Neurochemical Evidences.

  2020cites this paper
• Protective Effects of Agmatine Against Corticosterone-Induced Impairment on Hippocampal mTOR Signaling and Cell Death

  2020cites this paper
• The involvement of GABAergic system in the antidepressant-like effect of agmatine

  2020cites this paper
• Agmatine potentiates antidepressant and synaptic actions of ketamine: Effects on dendritic arbors and spines architecture and Akt/S6 kinase signaling.

  2020cites this paper
• Agmatine Modulates Anxiety and Depression-like Behaviour in Diabetic Insulin-Resistant Rats.

  2020cites this paper
• AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar–Kyoto rats

  2020influential citation
• Agmatine Improves the Behavioral and Cognitive Impairments Associated with Chronic Gestational Ethanol Exposure in Rats.

  2020cites this paper
• Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape

  2019influential citation
• Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors

  2019cites this paper
• Antidepressant-like effects of agmatine and NOS inhibitors in chronic unpredictable mild stress model of depression in rats: The involvement of NLRP inflammasomes.

  2019cites this paper
• Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators

  2019cites this paper
• Licorisoflavan A Exerts Antidepressant-Like Effect in Mice: Involvement of BDNF-TrkB Pathway and AMPA Receptors

  2019cites this paper
• Antidepressant drug-protein interactions studied by spectroscopic methods based on fluorescent carbon quantum dots

  2019cites this paper
• The antidepressant-like effect of guanosine is dependent on GSK-3β inhibition and activation of MAPK/ERK and Nrf2/heme oxygenase-1 signaling pathways

  2019cites this paper
• Role of Agmatine on Neuroglia in Central Nervous System Injury

  2019cites this paper
• Antidepressant and pro‐neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone

  2018cites this paper
• Prefrontal gene expression changes in mood disorders and suicide

  2018cites this paper
• Energy Metabolism and Autism: The Ameliorative Potential of Carnosine and Agmatine

  2018cites this paper
• Single administration of agmatine reverses the depressive‐like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine

  2018cites this paper
• Sulforaphane Alleviates Lipopolysaccharide-induced Spatial Learning and Memory Dysfunction in Mice: The Role of BDNF-mTOR Signaling Pathway.

  2018cites this paper
• Evidence of Reduced Agmatine Concentrations in the Cerebral Cortex of Suicides

  2018cites this paper
• Agmatine potentiates neuroprotective effects of subthreshold concentrations of ketamine via mTOR/S6 kinase signaling pathway

  2018cites this paper
• Prefrontal alterations in GABAergic and glutamatergic gene expression in relation to depression and suicide.

  2018cites this paper
• Metabolic strategies for the degradation of the neuromodulator agmatine in mammals.

  2018cites this paper
• Glutamatergic system and mTOR-signaling pathway participate in the antidepressant-like effect of inosine in the tail suspension test

  2017cites this paper
• Elevation of synaptic protein is associated with the antidepressant-like effects of ferulic acid in a chronic model of depression.

  2017cites this paper
• Agmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience?

  2017cites this paper
• Therapeutic potential of agmatine for CNS disorders

  2017cites this paper
• Signaling pathways underlying the antidepressant-like effect of inosine in mice

  2017cites this paper
• Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice.

  2016cites this paper
• Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression

  2016cites this paper
• Agmatine, a potential novel therapeutic strategy for depression.

  2016cites this paper